Shimadzu

IR Spectroscopy Market worth $1.6 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, April 3, 2024

The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.

Key Points: 
  • The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.
  • Back Office & Other Services segment accounted for the largest share of ~52% of the IR spectroscopy market in 2029.
  • Europe is expected to hold the second largest share of the IR spectroscopy market during the forecast period.
  • Europe held the second largest share of ~31% in the IR spectroscopy industry in 2029.

IR Spectroscopy Market worth $1.6 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, April 3, 2024

The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.

Key Points: 
  • The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.
  • Back Office & Other Services segment accounted for the largest share of ~52% of the IR spectroscopy market in 2029.
  • Europe is expected to hold the second largest share of the IR spectroscopy market during the forecast period.
  • Europe held the second largest share of ~31% in the IR spectroscopy industry in 2029.

Near Infrared Imaging Market Projected to Reach $3.60 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Monday, March 18, 2024

Near Infrared Imaging (NIRI) is transforming the landscape of non-invasive diagnostics with its capability to utilize wavelengths between 700 and 2500 nanometers, providing deep insights into biological tissues.

Key Points: 
  • Near Infrared Imaging (NIRI) is transforming the landscape of non-invasive diagnostics with its capability to utilize wavelengths between 700 and 2500 nanometers, providing deep insights into biological tissues.
  • The key players in the Near Infrared Imaging Market include Hamamatsu Photonics K.K., KARL STORZ SE & Co. KG, Olympus Corporation, Carl Zeiss AG, Shimadzu Corporation, and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Near Infrared Imaging Market.
  • "Dive into the Near Infrared Imaging Market Landscape: Explore 186 Pages of Insights, 558 Tables, and 22 Figures"

Near Infrared Imaging Market Projected to Reach $3.60 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Monday, March 18, 2024

Near Infrared Imaging (NIRI) is transforming the landscape of non-invasive diagnostics with its capability to utilize wavelengths between 700 and 2500 nanometers, providing deep insights into biological tissues.

Key Points: 
  • Near Infrared Imaging (NIRI) is transforming the landscape of non-invasive diagnostics with its capability to utilize wavelengths between 700 and 2500 nanometers, providing deep insights into biological tissues.
  • The key players in the Near Infrared Imaging Market include Hamamatsu Photonics K.K., KARL STORZ SE & Co. KG, Olympus Corporation, Carl Zeiss AG, Shimadzu Corporation, and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Near Infrared Imaging Market.
  • "Dive into the Near Infrared Imaging Market Landscape: Explore 186 Pages of Insights, 558 Tables, and 22 Figures"

Shimadzu Medical Systems USA receives HCAI Special Seismic Certification Preapproval for FLUOROspeed X1 RF system

Retrieved on: 
Wednesday, January 10, 2024

LONG BEACH, Calif., Jan.10, 2024 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, has received HCAI Special Seismic Certification preapproval for the FLUOROspeed X1.

Key Points: 
  • LONG BEACH, Calif., Jan.10, 2024 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, has received HCAI Special Seismic Certification preapproval for the FLUOROspeed X1.
  • The successful completion of certification ensures earthquake resistance capability and allows us to offer our latest patient side conventional RF table system with a multitude of features that improve workflow and operator efficiencies to healthcare facilities in California.
  • With its 31.5‐inch aperture opening between tabletop and deck, the X1 is the ideal digital RF system providing access for imaging patients in wheelchairs, yet it can fit in smaller rooms where space is limited.
  • Furthermore, by adding a second X‐ray tube on an overhead rail, the system functionality and versatility of the room increases exponentially.

PFAS Testing Market Worth $121 Million | MarketsandMarkets

Retrieved on: 
Monday, December 11, 2023

Key Market Players of PFAS Testing Industry:

Key Points: 
  • Key Market Players of PFAS Testing Industry:
    As of 2022, prominent players in PFAS testing are Merck KGaA (Germany), Agilent Technologies (US), LGC Limited (UK), Waters Corporation (US), Biotage (Sweden), AccuStandard, Inc. (US), PerkinElmer, Inc. (US), Thermo Fisher Scientific, Inc. (US), Phenomenex (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), and Shimadzu Corporation (Japan), among others.
  • In June 2022, MACHEREY-NAGEL GmbH & Co. KG introduced NUCLEODUR PFAS and PFAS Delay, HPLC columns for the analysis of per- and polyfluoroalkyl substances (PFAS).
  • PFAS Testing Market - Key Benefits of Buying the Report:
    The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share.
  • Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

PFAS Testing Market Worth $121 Million | MarketsandMarkets

Retrieved on: 
Monday, December 11, 2023

Key Market Players of PFAS Testing Industry:

Key Points: 
  • Key Market Players of PFAS Testing Industry:
    As of 2022, prominent players in PFAS testing are Merck KGaA (Germany), Agilent Technologies (US), LGC Limited (UK), Waters Corporation (US), Biotage (Sweden), AccuStandard, Inc. (US), PerkinElmer, Inc. (US), Thermo Fisher Scientific, Inc. (US), Phenomenex (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), and Shimadzu Corporation (Japan), among others.
  • In June 2022, MACHEREY-NAGEL GmbH & Co. KG introduced NUCLEODUR PFAS and PFAS Delay, HPLC columns for the analysis of per- and polyfluoroalkyl substances (PFAS).
  • PFAS Testing Market - Key Benefits of Buying the Report:
    The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share.
  • Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

IonOpticks and Newomics broaden chromatography accessibility for Agilent mass specs, with Shimadzu pending

Retrieved on: 
Wednesday, December 6, 2023

IonOpticks is renowned for its class-leading chromatography solutions, particularly the Aurora Series, which are celebrated for their precision, efficiency, and reliability in protein separation and analysis.

Key Points: 
  • IonOpticks is renowned for its class-leading chromatography solutions, particularly the Aurora Series, which are celebrated for their precision, efficiency, and reliability in protein separation and analysis.
  • This partnership underscores IonOpticks' commitment to broadening the accessibility and application of its top-tier chromatography technologies.
  • Thanks to Newomics' innovative development of the UniESI source, IonOpticks' Aurora Series columns are now seamlessly compatible with Agilent mass spectrometers.
  • This collaboration marks a significant advancement in IonOpticks' drive to empower all researchers with the best chromatography, regardless of the mass spec they are using, with a similar solution for Shimadzu mass specs coming soon.

IonOpticks and Newomics broaden chromatography accessibility for Agilent mass specs, with Shimadzu pending

Retrieved on: 
Wednesday, December 6, 2023

IonOpticks is renowned for its class-leading chromatography solutions, particularly the Aurora Series, which are celebrated for their precision, efficiency, and reliability in protein separation and analysis.

Key Points: 
  • IonOpticks is renowned for its class-leading chromatography solutions, particularly the Aurora Series, which are celebrated for their precision, efficiency, and reliability in protein separation and analysis.
  • This partnership underscores IonOpticks' commitment to broadening the accessibility and application of its top-tier chromatography technologies.
  • Thanks to Newomics' innovative development of the UniESI source, IonOpticks' Aurora Series columns are now seamlessly compatible with Agilent mass spectrometers.
  • This collaboration marks a significant advancement in IonOpticks' drive to empower all researchers with the best chromatography, regardless of the mass spec they are using, with a similar solution for Shimadzu mass specs coming soon.

Shimadzu Medical Systems USA receives an IMV ServiceTrak Award in the RF category for Best Service

Retrieved on: 
Tuesday, December 5, 2023

LONG BEACH, Calif., Dec. 5, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, receives an IMV ServiceTrak Award in the RF Category.

Key Points: 
  • LONG BEACH, Calif., Dec. 5, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, receives an IMV ServiceTrak Award in the RF Category.
  • In the recent, 2023 ServiceTrak, Shimadzu Medical Systems USA received the RF ServiceTrak Award for Best Service.
  • Shimadzu was presented the IMV Service Trak award during the recent RSNA exhibition in Chicago, IL.
  • Johnny Goossens, National Service Business Director emphasizes that, "We are extremely pleased to receive the IMV award for Best Service for our RF products.